Navigation Links
Thad Bench of Benchworks to Participate in 8th Annual Life Science Chief Executive Officer Forum
Date:3/22/2017

Benchworks CEO Thad L. Bench Sr. will participate in the 8th Annual Life Science Chief Executive Officer Forum on March 23-24 in San Diego. The event is a gathering of executive leadership from companies in the pharmaceutical, biotechnology and medical device and diagnostic industries.

Benchworks Vice President Christian Meyer will also participate in the forum. Participants will discuss the future of the life science industry and current challenges organizations face. The event is designed for education, engagement and knowledge sharing. A live polling feature will enable the audience to actively participate.

Thad Bench will interview the Founder, President & CEO of ARMO Biosciences, Peter Van Vlasselaer, PhD. The conversation will focus on Vlasselaer’s entrepreneurial experience and the need for leadership excellence in the biotech industry and will be conducted in front of an audience of attendees.

In addition, Thad Bench will serve as the chairperson for the forum events on March 24. He will introduce each session which include panel discussions on these topics:

•Assessing the Impact of Pricing Pressures on the Pharmaceutical Industry
•Regulatory Challenges and Solutions for Value-Based Pricing
•Business Models & Medical Device Contracting in a Value-Based Healthcare Environment
•Delivering on the Promise of Precision Medicine: Analysis of Impact on the Life Science Industry
•The Convergence of Technology & Healthcare

Commenting on the event, Thad Bench said, “This forum brings together leaders of the highest caliber who will share their knowledge and experiences in the biotech industry. It is an exciting opportunity for people to learn and benefit from their wisdom and experience. As a commercialization partner, we at Benchworks look forward to networking with executives to discuss how we can help them build out operations and provide strategic thinking, top-tier creative, and outstanding project management.”

About Benchworks
Benchworks, a comprehensive marketing services agency headquartered in Chestertown, Maryland, was founded in 1991. With offices in Philadelphia and Boston, the company specializes in the design, production, and launch of complete marketing and branding services. Clients include a wide variety of companies in the life science, pharmaceutical, beverage, manufacturing, and education industries in North America and Europe. For additional information, visit http://www.benchworks.com or call 800-536-4670.

Read the full story at http://www.prweb.com/releases/2017/03/prweb14167294.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Formaspace Debuts Innovative New Lab Bench at Pittcon 2017
2. Groundbreaking Technology in Drug Discovery: Shorten Wet-Bench Experimental Time and Reduce Animal Use in Research
3. Benchling Announces First Of Its Kind Molecular Biology 2.0 Software Enabling Scientists To Run Thousands Of Experiments At Once
4. Benchworks Marks 25 Years of Excellence in Life Science Marketing
5. Innovation in Clinical Research awarded to CEO of Benchmark Research
6. Benchmark Research Named Best Clinical Trial Site at VIE Awards
7. Benchmark Research announces the promotion of two long-standing Principal Investigators.
8. Now Open: iLab Solutions’ Sixth Annual Core Facility Management Benchmarking Survey
9. Benchmark Research Announced New Operating Structure
10. ResearchDx Appointment of New Chief Medical Officer to Meet NIH Push for Precision Medicine in Expediting Bench to Bedside" Strategies for Disease Treatment
11. With Disclosure of Recently Met Benchmarks for Its Adult Tissue Stem Cell Counting Technology, Asymmetrex Targets Applications to Enable Gene-Editing Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... A new study published ... frozen and fresh in vitro fertilization (IVF) transfer cycles. The multi-center ... success. , After comparing the results from the fresh and frozen transfer cohorts, ...
(Date:10/10/2017)... ... ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. spent ... entitled “Stem Cells and Their Regenerative Powers,” was held on August 31st, 2017 ... joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic Surgery, Grossmont ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
(Date:10/7/2017)... Phoenix, Arizona (PRWEB) , ... ... ... than 15 years’ experience providing advanced instruments and applications consulting for microscopy ... the in-house expertise in application consulting, Nanoscience Analytical offers a broad range ...
Breaking Biology Technology:
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
(Date:3/24/2017)... , Mar 24, 2017 Research and ... Access System Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 15.1% over the next ... This industry report analyzes the market estimates and forecasts for all ...
Breaking Biology News(10 mins):